Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 10 | 2024 | 3780 | 2.190 |
Why?
|
Myocardial Perfusion Imaging | 9 | 2024 | 672 | 2.130 |
Why?
|
Colchicine | 5 | 2024 | 257 | 2.070 |
Why?
|
Fractional Flow Reserve, Myocardial | 6 | 2024 | 346 | 1.810 |
Why?
|
Pericarditis | 3 | 2024 | 136 | 1.650 |
Why?
|
Coronary Artery Disease | 15 | 2024 | 6569 | 1.640 |
Why?
|
Myocardial Ischemia | 4 | 2023 | 2139 | 1.500 |
Why?
|
Troponin T | 4 | 2024 | 787 | 1.470 |
Why?
|
Coronary Circulation | 10 | 2024 | 1617 | 1.460 |
Why?
|
Cardiovascular Diseases | 16 | 2024 | 15662 | 1.440 |
Why?
|
Antirheumatic Agents | 4 | 2024 | 1381 | 1.400 |
Why?
|
Psoriasis | 4 | 2023 | 926 | 1.370 |
Why?
|
Atherosclerosis | 5 | 2024 | 3431 | 1.250 |
Why?
|
Rheumatic Diseases | 3 | 2024 | 663 | 1.230 |
Why?
|
Heart Auscultation | 2 | 2017 | 33 | 1.080 |
Why?
|
Anti-Inflammatory Agents | 5 | 2024 | 1813 | 0.990 |
Why?
|
Microcirculation | 4 | 2024 | 1281 | 0.990 |
Why?
|
Inflammation | 12 | 2024 | 10869 | 0.960 |
Why?
|
Chloroquine | 1 | 2024 | 275 | 0.840 |
Why?
|
Systemic Vasculitis | 1 | 2023 | 37 | 0.820 |
Why?
|
Heart Diseases | 4 | 2024 | 2819 | 0.820 |
Why?
|
Rheumatology | 2 | 2024 | 619 | 0.700 |
Why?
|
Hydroxychloroquine | 1 | 2024 | 426 | 0.690 |
Why?
|
Heart Injuries | 1 | 2021 | 207 | 0.670 |
Why?
|
Lupus Erythematosus, Systemic | 6 | 2024 | 2171 | 0.650 |
Why?
|
Inflammation Mediators | 3 | 2024 | 1890 | 0.650 |
Why?
|
Coronary Vessels | 6 | 2024 | 3124 | 0.610 |
Why?
|
Heart Sounds | 1 | 2017 | 17 | 0.570 |
Why?
|
Positron-Emission Tomography | 12 | 2024 | 6673 | 0.540 |
Why?
|
Autoimmunity | 1 | 2024 | 1360 | 0.530 |
Why?
|
Ventricular Dysfunction | 1 | 2017 | 144 | 0.520 |
Why?
|
Death, Sudden, Cardiac | 1 | 2024 | 1568 | 0.520 |
Why?
|
Stethoscopes | 1 | 2015 | 30 | 0.500 |
Why?
|
Breast Feeding | 1 | 2023 | 1364 | 0.480 |
Why?
|
Skin Diseases | 1 | 2023 | 1085 | 0.470 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 2258 | 0.460 |
Why?
|
Heart | 2 | 2023 | 4448 | 0.440 |
Why?
|
Biological Products | 1 | 2023 | 944 | 0.430 |
Why?
|
Thrombosis | 2 | 2024 | 2956 | 0.420 |
Why?
|
Cardiovascular System | 1 | 2020 | 840 | 0.410 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1751 | 0.400 |
Why?
|
Myocardium | 3 | 2024 | 4790 | 0.390 |
Why?
|
Ammonia | 2 | 2023 | 248 | 0.390 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2260 | 0.390 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2402 | 0.380 |
Why?
|
Lipoprotein(a) | 3 | 2024 | 490 | 0.370 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2011 | 72 | 0.370 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2024 | 2297 | 0.360 |
Why?
|
Predictive Value of Tests | 6 | 2024 | 15471 | 0.360 |
Why?
|
Tomography, Optical Coherence | 1 | 2024 | 2957 | 0.360 |
Why?
|
Humans | 64 | 2024 | 768887 | 0.350 |
Why?
|
Cardiomyopathies | 1 | 2022 | 2057 | 0.340 |
Why?
|
Peptide Fragments | 1 | 2021 | 5150 | 0.310 |
Why?
|
Myocardial Infarction | 4 | 2024 | 11521 | 0.300 |
Why?
|
Tissue Donors | 1 | 2017 | 2382 | 0.290 |
Why?
|
Interleukin-6 | 3 | 2023 | 3233 | 0.280 |
Why?
|
Risk Factors | 14 | 2024 | 74971 | 0.250 |
Why?
|
Treatment Outcome | 9 | 2024 | 65485 | 0.250 |
Why?
|
Cell Lineage | 2 | 2011 | 2576 | 0.250 |
Why?
|
Janus Kinases | 2 | 2024 | 253 | 0.250 |
Why?
|
Cardiac Imaging Techniques | 2 | 2024 | 281 | 0.230 |
Why?
|
Immunotherapy | 1 | 2020 | 4755 | 0.230 |
Why?
|
Heart Transplantation | 1 | 2017 | 3301 | 0.220 |
Why?
|
Heart Failure | 4 | 2022 | 11879 | 0.210 |
Why?
|
Takayasu Arteritis | 1 | 2024 | 106 | 0.210 |
Why?
|
Registries | 3 | 2024 | 8384 | 0.210 |
Why?
|
Echocardiography | 1 | 2015 | 5046 | 0.210 |
Why?
|
Rheumatic Heart Disease | 1 | 2024 | 164 | 0.210 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3269 | 0.200 |
Why?
|
Female | 31 | 2024 | 397464 | 0.200 |
Why?
|
Hypertension | 4 | 2024 | 8615 | 0.200 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2024 | 1141 | 0.200 |
Why?
|
Coronary Angiography | 2 | 2024 | 4541 | 0.190 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 2 | 2011 | 85 | 0.180 |
Why?
|
Vascular Resistance | 1 | 2024 | 939 | 0.180 |
Why?
|
Early Growth Response Transcription Factors | 1 | 2020 | 32 | 0.180 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3858 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 559 | 0.180 |
Why?
|
Aged | 15 | 2024 | 171790 | 0.180 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 307 | 0.170 |
Why?
|
Antigens, Human Platelet | 1 | 2020 | 41 | 0.170 |
Why?
|
Male | 25 | 2024 | 365249 | 0.170 |
Why?
|
Risk Assessment | 8 | 2024 | 24330 | 0.170 |
Why?
|
Pericardium | 1 | 2024 | 679 | 0.170 |
Why?
|
Drug Interactions | 1 | 2024 | 1421 | 0.170 |
Why?
|
Apolipoprotein A-I | 1 | 2021 | 305 | 0.170 |
Why?
|
T-Lymphocytes | 3 | 2011 | 10276 | 0.160 |
Why?
|
Apolipoproteins B | 1 | 2021 | 386 | 0.160 |
Why?
|
Middle Aged | 19 | 2024 | 223740 | 0.160 |
Why?
|
Interleukin-1 | 1 | 2023 | 1251 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.160 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2021 | 348 | 0.160 |
Why?
|
Prospective Studies | 6 | 2024 | 54950 | 0.160 |
Why?
|
Running | 1 | 2023 | 490 | 0.160 |
Why?
|
Calcium | 2 | 2023 | 5792 | 0.150 |
Why?
|
Lymphopoiesis | 1 | 2009 | 133 | 0.150 |
Why?
|
Interleukin-1beta | 1 | 2024 | 1027 | 0.150 |
Why?
|
Retinal Vessels | 1 | 2024 | 864 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 590 | 0.150 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 507 | 0.150 |
Why?
|
Viremia | 1 | 2020 | 725 | 0.140 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2020 | 577 | 0.140 |
Why?
|
Troponin | 1 | 2020 | 535 | 0.140 |
Why?
|
Action Potentials | 1 | 2024 | 1838 | 0.140 |
Why?
|
Vasodilator Agents | 1 | 2021 | 990 | 0.130 |
Why?
|
Retrospective Studies | 11 | 2024 | 81892 | 0.130 |
Why?
|
Dermatitis, Atopic | 1 | 2024 | 737 | 0.130 |
Why?
|
Cell Differentiation | 3 | 2011 | 11684 | 0.130 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2020 | 246 | 0.130 |
Why?
|
Prognosis | 7 | 2024 | 30044 | 0.120 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3116 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2024 | 1203 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1251 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3214 | 0.120 |
Why?
|
Clinical Medicine | 1 | 2015 | 145 | 0.110 |
Why?
|
Fatty Liver | 1 | 2020 | 810 | 0.110 |
Why?
|
Aspirin | 2 | 2023 | 3135 | 0.110 |
Why?
|
Ischemia | 1 | 2023 | 1900 | 0.110 |
Why?
|
Myeloid Cells | 1 | 2009 | 840 | 0.110 |
Why?
|
Venous Thromboembolism | 2 | 2024 | 1880 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2277 | 0.110 |
Why?
|
Triglycerides | 1 | 2021 | 2464 | 0.110 |
Why?
|
History, 19th Century | 1 | 2015 | 715 | 0.110 |
Why?
|
Toll-Like Receptors | 1 | 2006 | 582 | 0.100 |
Why?
|
Heart Rate | 1 | 2024 | 4217 | 0.100 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2830 | 0.100 |
Why?
|
Autoantigens | 1 | 2006 | 891 | 0.100 |
Why?
|
Cholesterol | 1 | 2021 | 2913 | 0.100 |
Why?
|
Kidney | 2 | 2024 | 7057 | 0.100 |
Why?
|
Receptor, Notch1 | 2 | 2011 | 520 | 0.090 |
Why?
|
Autoantibodies | 1 | 2020 | 2126 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2024 | 4207 | 0.090 |
Why?
|
Myeloid Progenitor Cells | 1 | 2011 | 112 | 0.090 |
Why?
|
Recurrence | 1 | 2023 | 8512 | 0.090 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2011 | 174 | 0.090 |
Why?
|
Genes, Essential | 1 | 2011 | 185 | 0.090 |
Why?
|
Animals | 10 | 2024 | 169408 | 0.080 |
Why?
|
Multipotent Stem Cells | 1 | 2011 | 201 | 0.080 |
Why?
|
Signal Transduction | 4 | 2024 | 23652 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2145 | 0.080 |
Why?
|
Drug Substitution | 2 | 2023 | 291 | 0.080 |
Why?
|
Up-Regulation | 2 | 2024 | 4148 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4265 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 2 | 2022 | 20776 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2763 | 0.070 |
Why?
|
Pain | 1 | 2023 | 5100 | 0.070 |
Why?
|
Hospitalization | 3 | 2024 | 10845 | 0.070 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2011 | 494 | 0.070 |
Why?
|
Pregnancy | 3 | 2024 | 30175 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12563 | 0.070 |
Why?
|
B-Cell Activating Factor | 1 | 2007 | 116 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2023 | 22294 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10397 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3982 | 0.070 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1240 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10591 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9384 | 0.070 |
Why?
|
B-Lymphocyte Subsets | 1 | 2007 | 241 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2011 | 1105 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5892 | 0.060 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 22381 | 0.060 |
Why?
|
Cohort Studies | 3 | 2022 | 41800 | 0.060 |
Why?
|
Pericarditis, Constrictive | 1 | 2024 | 46 | 0.060 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2007 | 547 | 0.060 |
Why?
|
Stroke Volume | 3 | 2022 | 5621 | 0.050 |
Why?
|
Dideoxynucleosides | 1 | 2023 | 135 | 0.050 |
Why?
|
Obesity | 2 | 2024 | 13087 | 0.050 |
Why?
|
Lamivudine | 1 | 2023 | 367 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1891 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2011 | 4291 | 0.050 |
Why?
|
Adult | 10 | 2024 | 223818 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2011 | 2820 | 0.050 |
Why?
|
Oxazines | 1 | 2023 | 358 | 0.050 |
Why?
|
Spleen | 1 | 2007 | 2294 | 0.050 |
Why?
|
Bone Marrow | 1 | 2011 | 2935 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2009 | 18366 | 0.050 |
Why?
|
Alanine | 1 | 2023 | 614 | 0.050 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2023 | 296 | 0.050 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2020 | 45 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 4032 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 140 | 0.040 |
Why?
|
B-Lymphocytes | 2 | 2009 | 4794 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2020 | 126 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 125 | 0.040 |
Why?
|
Pipecolic Acids | 1 | 2020 | 77 | 0.040 |
Why?
|
Mice | 7 | 2020 | 82074 | 0.040 |
Why?
|
Vaccination | 2 | 2022 | 3436 | 0.040 |
Why?
|
Microvessels | 1 | 2024 | 586 | 0.040 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2024 | 517 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2024 | 732 | 0.040 |
Why?
|
Culture Media, Serum-Free | 1 | 2009 | 148 | 0.040 |
Why?
|
Child, Preschool | 1 | 2022 | 42684 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1402 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4593 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2024 | 12469 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4415 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 819 | 0.040 |
Why?
|
Young Adult | 2 | 2022 | 60110 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2020 | 14485 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2020 | 19023 | 0.040 |
Why?
|
Antibody Formation | 1 | 2022 | 1393 | 0.040 |
Why?
|
Coronary Thrombosis | 1 | 2020 | 440 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1643 | 0.040 |
Why?
|
Drug Combinations | 1 | 2023 | 2088 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2020 | 301 | 0.040 |
Why?
|
HIV Infections | 1 | 2023 | 17589 | 0.030 |
Why?
|
Postpartum Period | 1 | 2024 | 1198 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1232 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2024 | 950 | 0.030 |
Why?
|
Arginine | 1 | 2020 | 932 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2081 | 0.030 |
Why?
|
Thymus Gland | 2 | 2011 | 1266 | 0.030 |
Why?
|
Antigens, CD19 | 1 | 2009 | 446 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21545 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15955 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20244 | 0.030 |
Why?
|
Prevalence | 2 | 2024 | 15875 | 0.030 |
Why?
|
Thrombectomy | 1 | 2020 | 675 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2011 | 5905 | 0.030 |
Why?
|
Antibodies, Antinuclear | 1 | 2006 | 343 | 0.030 |
Why?
|
Shock, Cardiogenic | 1 | 2020 | 711 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2663 | 0.030 |
Why?
|
Models, Immunological | 1 | 2006 | 518 | 0.030 |
Why?
|
Nucleic Acids | 1 | 2006 | 189 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5035 | 0.030 |
Why?
|
Piperazines | 1 | 2023 | 2553 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2006 | 962 | 0.030 |
Why?
|
Cardiology | 1 | 2024 | 1701 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5323 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3814 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2784 | 0.020 |
Why?
|
Warfarin | 1 | 2020 | 1493 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3398 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2053 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3216 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2011 | 12809 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1982 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4568 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2024 | 2965 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6320 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2011 | 826 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11934 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3335 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3382 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2011 | 5505 | 0.020 |
Why?
|
Stents | 1 | 2020 | 3200 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8559 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2023 | 4576 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9375 | 0.020 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 384 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3941 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2006 | 2323 | 0.020 |
Why?
|
Mitochondria | 1 | 2020 | 3683 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59738 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 812 | 0.020 |
Why?
|
Coronavirus Infections | 1 | 2024 | 3116 | 0.020 |
Why?
|
Pneumonia, Viral | 1 | 2024 | 3239 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1608 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2011 | 1714 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16735 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14795 | 0.020 |
Why?
|
Exons | 1 | 2011 | 2395 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2007 | 793 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7579 | 0.020 |
Why?
|
Pandemics | 1 | 2024 | 8745 | 0.010 |
Why?
|
United States | 2 | 2024 | 73180 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18454 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13677 | 0.010 |
Why?
|
Calcium Signaling | 1 | 2007 | 738 | 0.010 |
Why?
|
Time Factors | 1 | 2024 | 40266 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26384 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6085 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12430 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 18065 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17629 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 15603 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10486 | 0.010 |
Why?
|